Abstract: An apparatus for treating clubfoot is provided that includes a pair of vertically stacked and parallel cross bars that are connected to shoe attachment member via four hinges to define a parallelogram shaped gap therebetween. As the user raises a knee, one shoe attachment member can be displaced via the hinges (primarily in the y-axis or anterior/superior plane) relative to the other shoe attachment member, while the distance between the crossbars remains constant.

Abstract: Methods of detecting malate, and monitoring fibromyalgia, are provided.

Abstract: Disclosed herein are photopolymerization initiators of formula I. or a salt thereof. Also disclosed are compositions comprising the photopolymerization initiators of formula I and methods of using the photopolymerization initiators of formula I.

Abstract: A Descemet Membrane Endothelial Keratoplasty (DMEK) holder for placement within a vial for supporting a corneal tissue inserter is provided. The DMEK holder includes a top and an opposite bottom, at least one support member extending between the top and the bottom, with a bottom portion of the at least one support member sized and shaped to fit against a bottom inner surface of the vial to thereby support the corneal tissue inserter within the vial, and a first annular member having an opening sized and shaped such that a bottom end of the corneal tissue inserter is insertable through the opening and the first annular member separates the corneal tissue inserter from an inner surface of the vial and positions the corneal tissue inserter within the vial away from inner surfaces of the vial to thereby improve retrieval of the corneal tissue inserter by a surgeon.

Abstract: The invention provides compositions, kits and methods to treat a hyperproliferative disorder with an agent that increases expression of MCR1 and an MCR1 ligand. The invention also provides a method of treating drug-resistant melanoma, comprising administering an MCR1 ligand to a patient in need thereof. The present invention also provides in certain embodiments a melanoma-targeting conjugate comprising Formula I. T-L-X wherein T is a MCR1 ligand, L is a linker, and X an anti-cancer composition, for the therapeutic treatment of a hyperproliferative disorder. The present invention also provides methods, kits, and uses of the conjugate of Formula I.

Abstract: A medical draping system for enhancing patient privacy is provided. The system includes a first leg assembly extending upwardly. The system further includes a drape support operatively connected at a top end of the first leg assembly and configured such that in an operative position, the drape support extends at least partially across a patient examination table while spaced above the table. The system further includes at least one clip operatively connected to the drape support, each of the at least one clip configured to secure a sheet to the drape support such that the sheet hangs downwardly from the drape support onto the patient to provide privacy to the patient.

Abstract: In a first aspect, provided herein is a beta/MPZ family-subunit-eliminated (beta/MPZ?) engineered-cell comprising a cell with functionally inactivated SCN1B, SCN2B, SCN3B, SCN4B, MPZL1, MPZL2, MPZL3, MPZ and JAML genes. In certain aspects, the beta/MPZ? cell further comprising a defined engineered voltage-gated sodium channel, wherein the engineered voltage-gated sodium channel comprises a sodium channel alpha subunit, at least one sodium channel beta subunit.

Abstract: In certain embodiments, the present invention provides Qualitatively Mapping Amino Acid Properties (QMAP) cell culture media comprising an amino acid component, wherein the amino acids are present in the component at uniform concentrations; an inorganic salt component; an RPMI 1640 Vitamin Solution component; and auxiliary ingredient component. In certain aspects, the present invention also provides methods of making the QMAP cell culture media and using the QMAP cell culture media to culture cells.

Abstract: Disclosed are compositions, kits, and methods for identifying genes that are involved in T-cell trafficking. In particular, the compositions, kits, and methods may be used to identify genes involved in T-cell trafficking and/or infiltration into tumors such as genes that encode immune checkpoint regulators and/or stimulatory agents. The disclosed compositions, kits, and methods utilize the Sleeping Beauty® transposon system in a mouse tumor model to identify genes that are involved in T-cell trafficking and infiltration into tumors. The genes identified in the disclosed methods may provide immunotherapy targets in the tumor microenvironment. The identified genes may be utilized in order to develop therapies that enhance T-cell trafficking and infiltration into tumors and/or T-cell killing of tumors such as in chimeric antigen receptor (CAR) T cell therapies.

Abstract: A method of performing a chelating reaction comprising contacting a divalent metal with a compound of Formula (I): or a salt thereof wherein: each of R1-R4 is independently selected from the group consisting of CH2COORa and CH2C(?O)NHRa; each of R5-R12 is independently selected from the group consisting of II and -L-X; each Ra is independently selected from the group consisting of H and -L-X; each L is independently selected from the group consisting of absent and a linking group; and each X is a biological agent; and wherein the contacting occurs at a temperature below about 40° C. to form a chelated composition.

Abstract: A method for visualization of dynamic objects using a generative manifold includes steps of: acquiring a set of measurements associated with the dynamic objects using sensors; estimating parameters of a generator using the set of measurements and estimating latent variables using the set of measurements; modeling using a computing device the dynamic objects as a smooth non-linear function of the latent variables using the generator such that points in a latent subspace are mapped to a manifold in a generative manifold model; and generating a visualization of the dynamic objects using the generative manifold model. The set of measurements may include multi-slice data. The generative manifold model may provide for modeling deformations.

Abstract: A computer-based automated method of performing classification includes learning a deep neural network by maximizing an area under a receiver operating characteristic curve (AUC) or precision-recall curve (AUPRC) score wherein a margin-based surrogate loss function is applied, receiving an input into a deep neural network, and processing the input to the deep neural network to generate a prediction, wherein the prediction comprises a classification of the input. The computer-based automated method may be performed by executing instructions in at least one processor, and wherein said instructions are stored on a non-transitory memory readable by the at least one processor.

Abstract: Compounds and treatment methods with compounds exhibiting antiviral activity and/or inhibition of viral replication against viruses, particularly those belonging to the picornavirus-like supercluster, including coronavirus having a formula: or a prodrug or pharmaceutically-acceptable salt thereof, where: each X comprises at least one cyclic moiety directly attached to the oxygen or connected via an alkyl linkage, where at least one of the linkage and/or the X moiety comprises a deuterium substitution; and Z is selected from the group consisting of aldehydes and bisulfite salts, or the ester or carbamate prodrugs thereof.

Abstract: A recombinant mutant BoV genome is provided, as well as methods of using the vector, e.g., to prepare helper-free virus.

Abstract: The present embodiment is an implantable device capable of controlling cochlear implant electrode insertion and positioning. The embodiment uses an implanted mechanical positioning unit to advance position and monitor an electrode array. The device can be controlled via an external controller to reposition or advance an electrode array at any point after implantation with no surgical re-intervention. A cochlear implant electrode array whose position can be advanced and modified over time to best fit a patient's evolving hearing pattern would improve functional outcomes and significantly expand the candidacy range for cochlear implantation to include patients with substantial residual hearing.

Abstract: A method for measuring elevation of an accumulating resource with a visually distinguishable intersecting object includes providing an electronic device comprising a camera and at least one position sensor, performing at least one survey by obtaining sensor readings while the camera is aimed at an intersection, determining an altitude and pitch angle of the camera using the sensor readings; and computing the elevation of the accumulating resource using the geolocation and pitch angle of the camera.

Abstract: The invention provides compositions, kits and methods to treat a hyperproliferative disorder with an agent that increases expression of MCR1 and an MCR1 ligand. The invention also provides a method of treating drug-resistant melanoma, comprising administering an MCR1 ligand to a patient in need thereof. The present invention also provides in certain embodiments a melanoma-targeting conjugate comprising Formula I: T-L-X wherein T is a MCR1 ligand, L is a linker, and X an anti-cancer composition, for the therapeutic treatment of a hyperproliferative disorder. The present invention also provides methods, kits, and uses of the conjugate of Formula I.

Abstract: A method for machine learning includes learning, during a training stage, network parameter values of a neural network to obtain a trained neural network configured to perform reconstruction of medical images; refining, during a subsequent refinement stage, the learned network parameter values to generate refined network parameter values defining a refined neural network; and applying input medical image data to the refined neural network to generate a reconstructed medical image. The method retains benefits of machine learning image reconstruction to obtain a desired reconstructed image.

Abstract: A three-dimensional photo/electrodialysis unit includes four compartments. A first compartment holds a three-dimensional electrode and a group of one or more electrochemically active redox species. A first electroactive cation selective membrane couples the first compartment to a second compartment that provides a first feedstock. An electroactive anion selective membrane couples the second compartment to a third compartment that provides a second feedstock. And a second electroactive cation selective membrane couples the third compartment to a fourth compartment that holds a second group of one or more electrochemically active redox species.

Abstract: An apparatus and method of treatment of an animal using the apparatus are disclosed. The apparatus includes a scalpel, a laser included in the scalpel, and a visible light source included in the scalpel. The visible light source provides a visible targeting beam. The method of treatment includes activating a visible targeting beam in a laser scalpel. The visible targeting beam has an illumination intensity. The method further includes illuminating a tumor that includes cancerous cells and non-cancerous cells with the visible targeting beam, activating an invisible mid-infrared laser included in the scalpel to produce a laser spot at the tumor, and ablating the cancerous cells while leaving the non-cancerous cells substantially undamaged.